Meningioma risk communication in France

In September 2026, over 1 million women in France received letters informing them about the very low risk of meningioma, a type of brain tumor, associated with desogestrel, a hormone used in contraceptive pills. The letters were sent by the French National Agency for the Safety of Medicines and Health Products (ANSM) to provide clear information about this risk.

Focus on mastectomy patients

The Staph, a co-production of VIDAL and Pharmaradio, is launching a customized program in October 2026 that focuses on women who have undergone mastectomy, a surgical procedure to remove breast tissue, often due to cancer. This initiative aims to address specific health concerns and needs related to this patient group.

Pharmacist training on breast prostheses

The Staph is also exploring the training of pharmacists in the area of external breast prostheses, which are devices used to restore the appearance of the breast after mastectomy. The program emphasizes the importance of improving medication education and effectively communicating potential side effects without causing undue concern.

Case highlighting prosthesis issues

An official case of the month involves a woman who has been using an external breast prosthesis that is not well adapted for seven years. This case highlights the lack of awareness and understanding regarding the proper prescription and dispensation of these medical devices.

Staph team members

The Staph's October 2026 team includes several community pharmacists with specialized roles. These include Dr. Alice Bazile, founder of Epitop, and Dr. Cécile Guérard Detuncq, president of the association for the promotion of experimental pharmacies (Appex), among others. Each team member brings expertise in pharmacy, patient education, and public health advocacy.

Regulations and guidelines

Relevant regulations include the reimbursement of breast and hair prostheses by the French National Institute for Health and Medical Research (Inca) as of December 24, 2025, and a decree from June 18, 2026, which amends the conditions for registering external breast prostheses. These guidelines aim to improve access and standardization of these medical devices.

Epitop pink notebook

The Epitop pink notebook, published in 2026, offers further insights into the challenges and considerations surrounding breast prostheses and related health issues. It serves as a resource for healthcare professionals and patients alike.